5-Fluoro-2-Methylbenzoicum Acidum CAS 33184-16-6

Description:

Nomen chemicum: 5-Fluoro-2-Methylbenzoicum acidum

CAS: 33184-16-6

Dic: ≥98.0%

Aspectus: Alba vel Off-White pulveris

Intermedium de Rucaparib (CAS 283173-50-2) ad curationes Ovariani Cancri

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Manufacturer Supple, Puritas, Commercial Productio
Nomen chemicum: 5-Fluoro-2-Methylbenzoicum acidum
CAS: 33184-16-6

Chemical Properties:

Nomen chemicum 5-Fluoro-2-Methylbenzoicum Acid
Synonyma 5-Fluoro-o-toluic Acid
CAS Number 33184-16-6
CATTUS Number RF-PI414
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C8H7FO2
M. Pondus 154.14
Liquescens punctum 130,0 ad 132.0℃ (lit.)
Solubilitas Solutum in Methanol
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba vel Off-White pulveris
Assay ≥98.0%
Damnum in Siccatio ≤0.50%
Residere in Ignition ≤0.20%
Totalis immunditias ≤2.0%
Test Standard Enterprise Standard
Consuetudinem Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.

commoda:

1

FAQ:

Applicatio:

5-Fluoro-2-Methylbenzoicum acidum (CAS 33184-16-6) adhibitum est in praeparatione derivatorum iminothiazolium novorum sicut ligandi cannabinoidei receptoris.5-Fluoro-2-Methylbenzoicum Acidum in synthesi Rucaparib adhiberi potest (CAS 283173-50-2).Rucaparib adhibita est responsio ad alias curationes conservandas pro quibusdam generibus cancri ovarii (cancri incipientis in organis generationis feminae ubi ova formantur), tubus tubarum fallopianus (tubus qui ova onerariis ab ovariis uteri emissa), et primarius. peritonaeum (stratum texti quod abdominis lineat) cancri etiam tractari solebat cancer ovarii ovarii, tubus cancri tubarum, et cancer peritonaei primarius in hominibus cum gene speciali, qui post curationem cum duobus saltem aliis therapiis non emendavit.Rucaparib est in genere medicamentorum inhibitores (ADP-ribosi) polymerasi (PARP) inhibitores.Occisis cellulis cancer operatur.

Epistulam tuam hic scribe et mitte nobis